Biotech News

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

Embecta (EMBC)Embecta2026-06-25 13:46 ESTEarnings

PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.

Open original release

Related news

EMBCEmbecta2026-06-25 13:46 EST

embecta appoints Nimish Muzumdar as SVP and President, North America

EMBCEmbecta2026-06-25 13:46 EST

embecta to Participate in Investor Events

EMBCEmbecta2026-06-25 13:46 EST

embecta Completes Acquisition of Owen Mumford Holdings Limited

EMBCEmbecta2026-06-25 13:46 EST

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

EMBCEmbecta2026-06-25 13:46 EST

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

EMBCEmbecta2026-06-25 13:46 EST

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

EMBCEmbecta2026-06-25 13:46 EST

embecta to Report Fiscal First Quarter Financial Results

EMBCEmbecta2026-06-25 13:46 EST

embecta names new Chairman of the Board and Lead Independent Director

EMBCEmbecta2026-06-25 13:46 EST

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

EMBCEmbecta2026-06-25 13:46 EST

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

View all latest news

Embecta

Embecta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

EMBCEmbecta2026-06-26 13:24 EST

embecta appoints Nimish Muzumdar as SVP and President, North America

EMBCEmbecta2026-06-26 13:24 EST

embecta to Participate in Investor Events

EMBCEmbecta2026-06-26 13:24 EST

embecta Completes Acquisition of Owen Mumford Holdings Limited

EMBCEmbecta2026-06-26 13:24 EST

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

EMBCEmbecta2026-06-26 13:24 EST

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States